Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

PRLD holding history

Prelude Therapeutics Inc in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PRLD overviewAll 13F holders of PRLDFull Q2 2026 holdings

Shares (Q2 2026)
22,554
Value
$120.2K
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of PRLD by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202622,554$120.2K<0.1%−101,824−81.9%ReducedHolders
Q1 2026124,378$425.4K<0.1%+124,378NewHolders
Q3 20250$00.0%−33,625−100.0%Sold outHolders
Q2 202533,625$27.2K<0.1%+33,591+98,797.1%AddedHolders
Q1 202534$26<0.1%−10,263−99.7%ReducedHolders
Q4 202410,297$13.1K<0.1%−4,928−32.4%ReducedHolders
Q3 202415,225$31.5K<0.1%−16,163−51.5%ReducedHolders
Q2 202431,388$119.6K<0.1%+1,593+5.3%AddedHolders
Q1 202429,795$141.2K<0.1%−65,535−68.7%ReducedHolders
Q4 202395,330$407.1K<0.1%−204,771−68.2%ReducedHolders
Q3 2023300,101$927.3K<0.1%+263,232+714.0%AddedHolders
Q2 202336,869$165.9K<0.1%+36,869NewHolders
Q1 20230$00.0%−18,232−100.0%Sold outHolders
Q4 202218,232$110.1K<0.1%+2,498+15.9%AddedHolders
Q3 202215,734$104.0K<0.1%−93,889−85.6%ReducedHolders
Q2 2022109,623$572.0K<0.1%+58,725+115.4%AddedHolders
Q1 202250,898$352.0K<0.1%−87,602−63.3%ReducedHolders
Q4 2021138,500$1.73M<0.1%+124,005+855.5%AddedHolders
Q3 202114,495$453.0K<0.1%+14,495NewHolders
Q2 20210$00.0%−19,496−100.0%Sold outHolders
Q1 202119,496$845.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.